Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Nimish A. Mohile, M.D.
Nimish A. Mohile, M.D.

Nimish A. Mohile, M.D.

Neurology — Oncology — Neurology

Accepting New Patients

Nimish A. Mohile, M.D.

Neurology — Oncology — Neurology

Accepting New Patients


Locations

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-5830

About Me

A board certified neurologist with specialty training in neuro-oncology, Dr. Nimish Mohile completed his residency in neurology at Northwestern University followed by a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center. Dr. Mohile joined the faculty at the University of Rochester in 2007 where he has a joint appointment in neurology and oncology. He sees patients at the James P. Wilmot Cancer Center and at Strong Memorial Hospital.

Dr. Mohile sees patients with primary and metastatic brain tumors and is involved in administering chemotherapy, treating seizures and managing side effects of brain tumors and brain tumor therapy. In addition, he does consultations on patients with neurologic complications of cancer or cancer treatments.
His research focuses on understanding the role of cancer stem cells in the progression of brain tumors. He is interested in developing novel therapies for the treatment of all types of brain tumors and is currently the principal investigator of several clinical trials at the University of Rochester.

Credentials

Education:

MD | St. George's University School of Medicine — 2000

Post-doctoral Training & Residency:

Internship in Internal Medicine at Norwalk Hospital — 2000 - 2001
Residency in Neurology at Northwestern University Medical School — 2001 - 2004
Fellowship in at Memorial Sloan-Kettering Cancer Center — 2005 - 2007
Fellowship in Neurophysiology at Northwestern University Medical School — 2004 - 2005

Research

A board certified neurologist with specialty training in neuro-oncology, Dr. Nimish Mohile completed his residency in neurology at Northwestern University followed by a fellowship in neuro-oncology at Memorial Sloan-Kettering Cancer Center. Dr. Mohile joined the faculty at the University of Rochester in 2007 where he has a joint appointment in neurology and oncology. He sees patients at the James P. Wilmot Cancer Center and at Strong Memorial Hospital.

Dr. Mohile sees patients with primary and metastatic brain tumors and is involved in administering chemotherapy, treating seizures and managing side effects of brain tumors and brain tumor therapy. In addition, he does consultations on patients with neurologic complications of cancer or cancer treatments.
His research focuses on understanding the role of cancer stem cells in the progression of brain tumors. He is interested in developing novel therapies for the treatment of all types of brain tumors and is currently the principal investigator of several clinical trials at the University of Rochester.

Publications:

Gewandter JS, Dworkin RH, Finnerup NB, Mohile NA. "Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?" Pain.. 2017 158(1):30-33.

Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J. "A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma." CNS oncology.. 2017 6(1):29-43. Epub 2016 Sep 15.

Herr MM, Mohile NA, Barr PM, van Wijngaarden E, Brown EB, Rich DQ. "Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era." Clinical lymphoma, myeloma & leukemia.. 2016 Sep 0; 16(9):e123-e127. Epub 2016 Jun 08.

View All Publications